{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "EZH2",
                "DNA Alteration": "c.1936T>G",
                "GeneMutation": "p.Y646F Spliceregionvariant-GOF",
                "VariantAlleleFraction": "13.29%"
            },
            {
                "Gene": "KRAS",
                "DNA Alteration": "c.37G>T",
                "GeneMutation": "p.G12Y Nonsense-LOF",
                "VariantAlleleFraction": "6.41%"
            },
            {
                "Gene": "MAPK1",
                "DNA Alteration": "c.964G>A",
                "GeneMutation": "p.E322K Spliceregionvariant-LOF",
                "VariantAlleleFraction": "1.26%"
            },
            {
                "Gene": "XPC",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.S346P Frameshift-GOF",
                "VariantAlleleFraction": "1.45%"
            },
            {
                "Gene": "PIK3CA",
                "DNA Alteration": "c.1635G>C",
                "GeneMutation": "p.E542K Stopgain-LOF",
                "VariantAlleleFraction": "9.06%"
            },
            {
                "Gene": "ZEB2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.H1038R Nonsense-GOF",
                "VariantAlleleFraction": "7.92%"
            },
            {
                "Gene": "KLF1",
                "DNA Alteration": "c.892G>C",
                "GeneMutation": "p.M39L Nonsense-GOF",
                "VariantAlleleFraction": "5.8%"
            },
            {
                "Gene": "NCSTN",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.A572G Spliceregionvariant-GOF",
                "VariantAlleleFraction": "3.84%"
            }
        ],
        "Germline": [
            {
                "Gene": "ERBB2",
                "DNA Alteration": "c.2524G>A",
                "GeneMutation": "p.L755X Missensevariant(exon2)-GOF",
                "Condition": "charge"
            }
        ]
    }
}